1995
ù¹ø° Ç÷°ü¼ºÇü¼ú ÇÐȸ(Angioplasty Summit)°¡ ¼¿ï¾Æ»êº´¿øÀÇ ´ë°´ç¿¡¼ °³ÃֵǾú½À´Ï´Ù.
1997
¹Ì±¹ Cardiovascular Research Foundation (CRF)ÀÇ Chief Medical OfficialÀÎ °Ô¸® ¹ÎÃ÷°¡ Á¶Á÷À§¿øȸ¿¡ Âü¿©ÇÏ¿´½À´Ï´Ù.
2000
Çѱ¹¿¡¼ ÃÖÃÊ·Î ¹Ì±¹ TCTÇÐȸ¿¡ °æÇÇÀû ÁßÀç¼úÀ» À§¼º Áß°è·Î ¼ÛÃâÇÏ¿´½À´Ï´Ù.
2001
¸»ÃÊ Ç÷°ü ÁßÀ縦 Æ÷ÇÔÇÑ ½ÉÇ÷°ü¿¡ °ü·ÃµÈ Æø³ÐÀº ÁÖÁ¦µéÀÌ ´Ù·ïÁ³½À´Ï´Ù.
2002
½ÉÀåÇ÷°ü¿¬±¸Àç´Ü(CVRF)ÀÌ ¼³¸³µÇ¾ú°í, °ü»óµ¿¸Æ ÁßÀç½Ã¼ú ±¹Á¦ÇмúȸÀÇ(TCTAP)°¡ ½ÉÀåÇ÷°ü¿¬±¸Àç´ÜÀÇ Áö¿øÀ¸·Î ü°èÀûÀ¸·Î ¿î¿µµÇ±â ½ÃÀÛÇß½À´Ï´Ù.
2003
Àü¹®°¡ ±³À° ¹× Àü ¼¼°èÀÇ ¿¬±¸ÀÚ, ÀÇ·áÀÎ, ¾÷°è °£ÀÇ Ä¿¹Â´ÏÄÉÀ̼ÇÀ» °³¼±ÇÏ°íÀÚ ÇÏ´Â ¸ñÀûÀ¸·Î Summitmd.com¸¦ °³¼³ÇÏ¿´½À´Ï´Ù.
2004
¾à200¸íÀÇ ÆÑÄÃƼ¸¦ Æ÷ÇÔÇÑ Àü¼¼°è¿¡¼ Âü¿©ÇÏ´Â 2,000¿©¸íÀÇ Âü°¡ÀÚµéÀ» ¼ö¿ëÇϱâ À§ÇÏ¿© ÇÐȸÀåÀ» ¼¿ï ¿öÄ¿Èú ½¦¶óÅæ È£ÅÚ·Î È®Àå ÀÌÀüÇÏ¿´½À´Ï´Ù. äÅÃµÈ ÃÊ·ÏÀÌ International Journal of Cardiovascular Intervention (IJCI)ÀÇ Æ¯º°ÆÇÀ¸·Î ÃâÆǵǾú½À´Ï´Ù.
2005
10ÁÖ³âÀ» ¸ÂÀÌÇÏ¿© ¹Ì±¹ÀÇ Cardiovascular Research Foundation(CRF)¿ÍÀÇ °øµ¿ ÈÄ¿ø ÇÏ¿¡ ÇÐȸ¸íÀ» Angioplasty Summit-TCT Asia PacificÀ¸·Î º¯°æÇÏ¿´½À´Ï´Ù. EuroPCRÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÇØ¿Ü ±×·ìµéÀÌ Çмú ÇÁ·Î±×·¥ °³¹ß¿¡ Âü¿©Çϱ⠽ÃÀÛÇß½À´Ï´Ù. ÃÊ·ÏÀÌ American Journal of Cardiology (AJC)¿¡ ÃâÆǵǾú½À´Ï´Ù.
2008
µÎ¹ø° ÁÂÁÖ°£ºÎ¿Í ºÐÁö ÇÐȸ(Left Main and Bifurcation Summit)°¡ Á¦13ȸ Ç÷°ü¼ºÇü¼ú ÇÐȸ(Angioplasty Summit)¿Í ÇÔ²² ¿·È½À´Ï´Ù.Endovascular Arena¿¡¼ Ç÷°ü ºÐ¾ßÀÇ Èï¹Ì·Î¿î ÁÖÁ¦¿Í »õ·Î¿î ±â±â, ÀÓ»ó °á°ú¸¦ ´Ù·ç¾ú½À´Ï´Ù.
2010
ÇÐȸ¸íÀ» Ç÷°ü¼ºÇü¼ú °ü»óµ¿¸Æ ÁßÀç½Ã¼ú ±¹Á¦ÇмúȸÀÇ(ANGIOPLASTY SUMMIT-TCTAP)·Î º¯°æÇÏ¿´½À´Ï´Ù. ¾Õ¼°¡´Â ÁßÀç ½ÉÀåÇÐ ÇÐȸ·Î¼ Áõ°Å ±â¹Ý ½Ç½À¿¡ »Ñ¸®¸¦ µÐ FFR ¹× TAVI¿¡ ´ëÇÑ ½ÅÈï ºÐ¾ß¿Í °ü½Éµµ ³ôÀº ÁÖÁ¦°¡ ³íÀǵǾú½À´Ï´Ù.
2011
ȯÀÚ Ä¡·áÀÇ ±âº» ¿øÄ¢À» ÀÌÇØÇÏ°í Àû¿ëÇÏ¸ç °¢ ÁÖÁ¦¿¡ ´ëÇÑ ÃֽŠ°³³ä°ú Áö½ÄÀ» ¾ò¾î¾ß ÇÏ´Â Æç·Î¿ì, ÀþÀº ½ÉÀå Àü¹®ÀÇ ¹× ¸ðµç °Ç° °ü·Ã Àü¹®°¡¸¦ À§ÇØ TCTAP Fellowship Course°¡ ½ÃÀ۵Ǿú½À´Ï´Ù. ½ÉÇ÷°ü ÀÇÇÐ ºÐ¾ß¿Í TCTAPÀÇ ¼ºÀå¿¡ ÀÇ¹Ì ÀÖ´Â °øÇåÇÑ ºÐµé¿¡°Ô °¨»çÀÇ ¸¶À½À» ±â¸®±â À§ÇÑ ¸ñÀûÀ¸·Î Á¦1ȸ TCTAP ¡°Master of the Masters¡±°¡ ¼ö¿©µÇ¾ú½À´Ï´Ù.
2012
Partnership Session with Global Societies¿¡ ´õ ¸¹Àº ±Û·Î¹ú ÆÄÆ®³ÊµéÀÌ Âü¿©ÇÏ¿´½À´Ï´Ù. Çѱ¹¿¡¼ óÀ½À¸·Î ½ÅÀå ½Å°æÂ÷´Ü¼ú ¹× °æÇÇÀû ´ëµ¿¸Æ ÆǸ· ġȯ¼ú (TAVI)ÀÇ ¶óÀÌºê ½Ã¿¬ÀÌ ¼öÇàµÇ¾ú½À´Ï´Ù.
2013
°ÀÇ, »ç·Ê¿¬±¸, ¶óÀÌºê ½Ã¿¬À¸·Î ±¸¼ºµÈ CTO LIVE°¡ °³ÃֵǾú½À´Ï´Ù.
ÀþÀº ÀÓ»ó ¿¬±¸ÀÚµéÀ» µ¶·ÁÇϱâÀ§ÇØ TCTAP ÀþÀº °úÇÐÀÚ »ó¡±(Best Young Scientist Award)ÀÌ »õ·Ó°Ô â¼³µÇ¾ú½À´Ï´Ù.
2014
18°³±¹ 45°³ ±Û·Î¹ú ÆÄÆ®³Ê¿Í ÇÐȸµéÀÌ ÇÁ·Î±×·¥ ±¸¼º¿¡ Âü¿©Çß½À´Ï´Ù.
½É»ç¸¦ °ÅÃÄ Ã¤ÅÃµÈ ¸ðµç ÃÊ·ÏÀÌ ¹Ì±¹ ½ÉÀåÇÐȸÁö(JACC)ÀÇ Áõº¸ÆÇ ¿Â¶óÀÎ Çü½ÄÀ¸·Î ÃâÆǵǾú½À´Ï´Ù.
2015
TCTAP ÇÐȸ°¡ 20ÁÖ³âÀ» ¸ÂÀÌÇß½À´Ï´Ù.
2016
À¯¿ëÇÑ Á¤º¸¿Í ¼ÒÁßÇÑ ¼ø°£µéÀ» °øÀ¯Çϱâ À§Çؼ ½ÉÀåÇ÷°ü¿¬±¸Àç´ÜÀÇ °ø½Ä Facebook ÆäÀÌÁö¸¦ ½Å¼³ÇÏ¿´½À´Ï´Ù. ¿Â¶óÀÎÀ» ÅëÇØ Âü°¡ÀÚµéÀÌ °ÀÇ¿Í ¶óÀÌºê ½Ã¿¬À» ½ÃûÇÒ ¼ö ÀÖµµ·Ï À¥Ä³½ºÆ® ¼ºñ½º¸¦ ·±ÄªÇÏ¿´½À´Ï´Ù.
2017
ÇÐȸ¸¦ ÅëÇØ CTO, Endovascular, Coronary, Valve¸¦ Æ÷ÇÔÇÑ ´Ù¾çÇÑ Èï¹Ì·Î¿î ÁÖÁ¦µéÀ» ´Ù·ç¾ú½À´Ï´Ù.
Âü°¡ÀÚµéÀÌ ½Ã°ø°£Àû Á¦¾à¾øÀÌ ÀÚ·á¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Æ÷½ºÅÍ ÃÊ·Ï ¼¼¼Ç¿¡ µðÁöÅÐ Çü½ÄÀ» µµÀÔÇÏ¿´½À´Ï´Ù. ¶ÇÇÑ, TCTAP ¿ä¾à ÀÎÅͺ並 À¥Ä³½ºÆ®¸¦ ÅëÇØ ½Ç½Ã°£À¸·Î ½ÃûÇÒ ¼ö ÀÖµµ·Ï ½Ã½ºÅÛÀ» ±¸ÃàÇß½À´Ï´Ù.
2019
Âü¼®Àڵ鿡°Ô ±âÃÊ°ÀÇ, ½Ç½À±³À° µî ½Ç¹«ÀûÀÎ ÇнÀ ±âȸ¸¦ Á¦°øÇϱâ À§Çؼ ÈÄ¿ø»ç¿¡¼ ¿î¿µÇÏ´Â Æ®·¹ÀÌ´× ÄÚ½º¸¦ È®´ëÇÏ¿´½À´Ï´Ù.
ACT Program 10ÁÖ³âÀ» ±â³äÇϱâ À§ÇÏ¿©, ACT ȨĿ¹Ö ¼¼¼ÇÀÌ ¸¶·ÃµÇ¾ú½À´Ï´Ù.
2020
TCTAPÇÐȸ°¡ Äڷγª ½Ã±¹À¸·Î ÀÎÇØ ´ÜÀýµÈ ±³À° ±âȸ¸¦ Áö¼ÓÀûÀ¸·Î Á¦°øÇϱâ À§ÇØ AP VALVESÇÐȸ¿Í ÅëÇÕÇÏ¿© ¿Â¶óÀÎÀ¸·Î °³ÃֵǾú½À´Ï´Ù.
¿Â¶óÀÎ ÇÐȸÀÇ ´ÜÁ¡ÀÎ ¼ÒÅë ±â´ÉÀÇ ºÎÀ縦 º¸¿ÏÇÏ°íÀÚ ±¹³»¿Ü °¢ºÐ¾ß Àü¹®°¡µéÀ» ¶óÀ̺ê äÆà Åä·ÐÀÚ·Î ÃÊûÇÏ¿© Âü°¡ÀÚµéÀÌ Àû±ØÀûÀ¸·Î Q&A¸¦ ÇÒ ¼ö ÀÖµµ·Ï '¶óÀ̺ê äÆà ¼ºñ½º'¸¦ Á¦°øÇÏ¿´½À´Ï´Ù.
2021
¿Â¶óÀÎ »óÀÇ ¼ÒÅë °È¸¦ À§ÇØ ÆäÀ̽ººÏ, ÀνºÅ¸±×·¥, Æ®À§ÅÍ, À¯Æ©ºê µîÀÇ °ø½Ä ¼Ò¼È³×Æ®¿öÅ©¼ºñ½º(SNS) ä³ÎÀ» °³Æí ¹× °³¼³Çß½À´Ï´Ù.
±¹³»¿Ü Âü°¡ÀÚµé Áß ¡°Social Media Ambassador¡±À» ¼±Á¤ÇÏ¿© SNS °ø½Ä °èÁ¤¿¡ »çÁø, µ¿¿µ»ó, ÇÏÀ̶óÀÌÆ®, Èï¹Ì·Î¿î ÄÜÅÙÃ÷¸¦ °Ô½ÃÇÏ´Â µî ¿Â¶óÀÎ ¼ÒÅë ¹× Á¤º¸ °øÀ¯ÀÇ ±âȸ¸¦ È®´ëÇÏ¿´½À´Ï´Ù.
2022
°è¼ÓµÇ´Â ¿Â¶óÀÎ ÇÐȸÀÇ Áö·çÇÔÀ» ´ú°í ÃֽŠƮ·»µå¸¦ ¹Ý¿µÇÏ°íÀÚ ¸ÞŸ¹ö½º ÄÁ¼ÁÀ» ȨÆäÀÌÁö¿¡ Á¢¸ñÇØ °ü°´µé¿¡°Ô »õ·Î¿î °æÇèÀ» ¼±»çÇß½À´Ï´Ù. TCTAPÇÐȸ¿¡ ´ëÇÑ Èï¹Ì·Î¿î ÄÜÅÙÃ÷¸¦ Á¦°øÇÏ°í, °ø°£ÀÇ Á¦¾à ¾øÀÌ ¼·Î ¼ÒÅëÇÒ ¼ö ÀÖ´Â ±â´ÉÀ» Á¦½ÃÇÒ ¼ö ÀÖ¾ú½À´Ï´Ù.
2023
TCTAPÇÐȸ°¡ Áö³ 3³â°£ÀÇ ¿Â¶óÀÎ ÇÐȸ ÀÌÈÄ ÇÏÀ̺긮µå Çü½ÄÀ¸·Î °³ÃÖµÇ¾î ¿Â¶óÀÎ Âü°¡ÀÚ¿Í ÇöÀå Âü°¡ÀÚ ¸ðµÎ¿¡°Ô »õ·Î¿î ÇüÅÂÀÇ Ä¿¹Â´ÏÄÉÀÌ¼Ç ±âȸ¸¦ Á¦°øÇß½À´Ï´Ù.